Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
7.63
+0.27 (3.67%)
Nov 21, 2024, 12:44 PM EST - Market open
Health Catalyst Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
Revenue | 302.06 | 295.94 | 276.24 | 241.93 | 188.85 | 154.94 | Upgrade
|
Revenue Growth (YoY) | 4.15% | 7.13% | 14.18% | 28.11% | 21.88% | 37.63% | Upgrade
|
Cost of Revenue | 162.59 | 161.11 | 140.68 | 124.17 | 98.08 | 75.24 | Upgrade
|
Gross Profit | 139.47 | 134.83 | 135.56 | 117.76 | 90.77 | 79.7 | Upgrade
|
Selling, General & Admin | 103.32 | 111.06 | 144.37 | 132.32 | 96.5 | 78.69 | Upgrade
|
Research & Development | 58.93 | 68.5 | 69.23 | 61.83 | 53.52 | 46.22 | Upgrade
|
Operating Expenses | 203.72 | 221.78 | 261.89 | 231.68 | 168.74 | 134.12 | Upgrade
|
Operating Income | -64.25 | -86.96 | -126.33 | -113.92 | -77.97 | -54.42 | Upgrade
|
Interest Expense | -11.62 | -7.29 | -7.24 | - | -11.57 | -3.42 | Upgrade
|
Interest & Investment Income | 17.56 | 16.39 | 5.69 | - | - | - | Upgrade
|
Other Non Operating Income (Expenses) | -0.14 | 0 | -0.13 | -16.46 | - | - | Upgrade
|
EBT Excluding Unusual Items | -58.45 | -77.85 | -128.01 | -130.38 | -89.54 | -57.84 | Upgrade
|
Merger & Restructuring Charges | -17.24 | -14.58 | -13.32 | -7.89 | -2.67 | -0.45 | Upgrade
|
Asset Writedown | -3.6 | -4.08 | -5.02 | -1.8 | - | - | Upgrade
|
Legal Settlements | - | -21.28 | - | - | - | - | Upgrade
|
Other Unusual Items | - | - | 4.67 | -20.04 | -24 | -1.67 | Upgrade
|
Pretax Income | -79.29 | -117.79 | -141.68 | -160.11 | -116.21 | -59.95 | Upgrade
|
Income Tax Expense | -0.15 | 0.36 | -4.28 | -6.9 | -1.19 | 0.14 | Upgrade
|
Earnings From Continuing Operations | - | -118.15 | -137.4 | -153.21 | -115.02 | -60.1 | Upgrade
|
Net Income | -79.14 | -118.15 | -137.4 | -153.21 | -115.02 | -60.1 | Upgrade
|
Preferred Dividends & Other Adjustments | - | - | - | - | - | 180.83 | Upgrade
|
Net Income to Common | -79.14 | -118.15 | -137.4 | -153.21 | -115.02 | -240.92 | Upgrade
|
Shares Outstanding (Basic) | 59 | 56 | 54 | 47 | 40 | 19 | Upgrade
|
Shares Outstanding (Diluted) | 59 | 56 | 54 | 47 | 40 | 19 | Upgrade
|
Shares Change (YoY) | 6.20% | 4.32% | 13.86% | 20.12% | 110.98% | 290.57% | Upgrade
|
EPS (Basic) | -1.34 | -2.09 | -2.56 | -3.23 | -2.91 | -12.86 | Upgrade
|
EPS (Diluted) | -1.34 | -2.09 | -2.63 | -3.23 | -2.91 | -12.86 | Upgrade
|
Free Cash Flow | -2.41 | -34.32 | -37.44 | -33.57 | -33.92 | -34.2 | Upgrade
|
Free Cash Flow Per Share | -0.04 | -0.61 | -0.69 | -0.71 | -0.86 | -1.82 | Upgrade
|
Gross Margin | 46.17% | 45.56% | 49.07% | 48.68% | 48.06% | 51.44% | Upgrade
|
Operating Margin | -21.27% | -29.38% | -45.73% | -47.09% | -41.29% | -35.12% | Upgrade
|
Profit Margin | -26.20% | -39.92% | -49.74% | -63.33% | -60.91% | -155.49% | Upgrade
|
Free Cash Flow Margin | -0.80% | -11.60% | -13.55% | -13.88% | -17.96% | -22.07% | Upgrade
|
EBITDA | -32.08 | -53.24 | -84.83 | -78.79 | -59.94 | -45.71 | Upgrade
|
EBITDA Margin | -10.62% | -17.99% | -30.71% | -32.57% | -31.74% | -29.50% | Upgrade
|
D&A For EBITDA | 32.17 | 33.72 | 41.5 | 35.13 | 18.03 | 8.71 | Upgrade
|
EBIT | -64.25 | -86.96 | -126.33 | -113.92 | -77.97 | -54.42 | Upgrade
|
EBIT Margin | -21.27% | -29.38% | -45.73% | -47.09% | -41.29% | -35.12% | Upgrade
|
Revenue as Reported | 302.06 | 295.94 | 276.24 | 241.93 | 188.85 | 154.94 | Upgrade
|
Advertising Expenses | - | 2.6 | 5.7 | 4.4 | 4.3 | 4.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.